By Giulia Corso|2024-09-05T11:59:39+00:00September 5th, 2024|collaboration, EU funded project, recent highlights, telomerized cells|
New review published by LifeSaver Project Consortium September 5th, 2024, Vienna, Austria The LifeSaver Project Consortium has published a comprehensive review
By Giulia Corso|2024-08-19T07:15:43+00:00August 19th, 2024|distributors, recent highlights|
Partnering with Chameleon Science August 19th, 2024, Vienna, AustriaWe are thrilled to announce that we have partnered with the new distributor Chameleon
By Giulia Corso|2024-08-29T12:11:50+00:00August 13th, 2024|cell line development, recent highlights cell line development, telomerized cells|
Newly released telomerized amniotic epithelial cells August 13th, 2024, Vienna, AustriaWe are thrilled to announce the newest addition to our cell portfolio: Telomerized
By Giulia Corso|2024-06-27T08:32:44+00:00June 27th, 2024|cell line development, conferences, EV cell factories, extracellular vesicles, organ-on-a-chip|
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at the
By Giulia Corso|2024-08-06T12:54:53+00:00February 16th, 2024|PODO/TERT256, telomerized cells|
Recent publication showcasing our PODO/TERT256 telomerized cell line February 16th, 2024, Vienna, AustriaOur telomerized human podocyte cells (PODO/TERT256) were employed in an article recently
